Medical Devices Japan

Japan Ophthalmic Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Ophthalmic Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Disease, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.85 Bn Placeholder estimate
Estimate 2025 $3.02 Bn 6.7% of the global market
Projected 2034 $5.20 Bn 71.8% Adds $2.17 Bn over 9 forecast years
CAGR 2025–2034 6.2% Faster than 9% of 180 Medical Devices markets here
Key players 6 +1
  • Japan is 6.73% of the global market.
  • In APAC, the largest is China at $3.24 Bn.
  • Fastest growing: India at 8.8% a year.
  • Japan ranks 2nd of 14 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.17 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Ophthalmic Devices Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.85 Bn — —
2025 (base) $3.02 Bn +$176.6 Mn —
2026 (forecast) $3.21 Bn +$187.5 Mn +6.2%
2027 (forecast) $3.41 Bn +$199.2 Mn +12.8%
2028 (forecast) $3.62 Bn +$211.5 Mn +19.8%
2029 (forecast) $3.85 Bn +$224.6 Mn +27.2%
2030 (forecast) $4.09 Bn +$238.6 Mn +35.1%
2031 (forecast) $4.34 Bn +$253.4 Mn +43.5%
2032 (forecast) $4.61 Bn +$269.1 Mn +52.4%
2033 (forecast) $4.89 Bn +$285.8 Mn +61.8%
2034 (forecast) $5.20 Bn +$303.5 Mn +71.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Ophthalmic Devices Market Analysis at a glance
Market size, 2025$3.02 Bn placeholder estimate
Forecast, 2034$5.20 Bn placeholder estimate
Growth (CAGR), 2025–20346.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, disease and end user (see all)
Key playersAlcon, Johnson & Johnson, Bausch and Lomb, Carl Zeiss Meditec, The Cooper Companies Inc. and 1 more (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Ophthalmic Devices Market Analysis Executive Summary

Ophthalmic devices diagnose and treat eye disease and vision problems, from eye scanners to surgical lasers and lenses.

Key segments of the ophthalmic devices market include product (Surgical Devices, Diagnostic and Monitoring Devices and Vision Correction) and disease (Cataract, Glaucoma and Retinal Disorders).

Bar chart: Japan Ophthalmic Devices market size, 2024–2034, placeholder estimates. $2.85 Bn in 2024, $3.02 Bn in 2025 and $5.20 Bn in 2034, 6.2% CAGR.
Japan Ophthalmic Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Ophthalmic Devices Market Dynamics

Market Growth Drivers

An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the ophthalmic devices market.

Opportunity

Smart implants, less invasive techniques and growing access to surgery in emerging economies give the ophthalmic devices market room to grow.

Market Restraints

Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the ophthalmic devices market.

Competitive Landscape for Ophthalmic Devices Market in Japan

The ophthalmic devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Ophthalmic Devices Market in Japan

Ophthalmic Devices in Japan: rules and payment

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ophthalmic devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Ophthalmic Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Ophthalmic Devices in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Ophthalmic Devices market in Japan?
Placeholder estimate: about $3.02 Bn in 2025, rising to about $5.20 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Ophthalmic Devices market in Japan growing?
Placeholder estimate: about 6.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Ophthalmic Devices market report cover?
The report splits the market by product (Surgical Devices, Diagnostic and Monitoring Devices, Vision Correction, Contact Lenses), disease (Cataract, Glaucoma, Retinal Disorders, Refractive Errors) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Ophthalmic Devices market?
Key players include Alcon, Johnson & Johnson, Bausch and Lomb, Carl Zeiss Meditec, The Cooper Companies Inc. and EssilorLuxottica.
What is driving the Ophthalmic Devices market?
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the ophthalmic devices market.
Who regulates Ophthalmic Devices in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How much research is published on Ophthalmic Devices?
PubMed lists 34 papers on Ophthalmic Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 20 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on eye health and diagnostics and lab testing

See the topic